نتایج جستجو برای: combination drug therapy

تعداد نتایج: 1451984  

Journal: :the journal of tehran university heart center 0
hilman zulkifli amin faculty of medicine, universitas indonesia, jakarta, indonesia. siska suridanda danny department of cardiology and vascular medicine, faculty of medicine, universitas indonesia, jakarta, indonesia.

heart failure (hf) is still a major problem worldwide with high morbidity and mortality rates. the recently developed medication for hf is still incapable of reducing its morbidity and mortality, and clinical data supporting the efficacy and safety of its mainstay therapy remain insufficient. arginine-vasopressin (avp) plays important roles in circulatory and water homeostasis, one of which is ...

ژورنال: زیست شناسی ایران 2020

The high affinity of baricitinib for the numb-associated kinase (NAK) family, its anti-inflammatory properties, with its advantageous pharmacokinetic properties, appear to make it a special case among the approved drugs.  In addition, the potential for combination therapy with baracitinib is high, because of its low plasma protein binding and minimal interaction with CYP enzymes and drug transp...

2013
Dao-Jun Gong Jia-Min Zhang Min Yu Bo Zhuang Qing-Qu Guo

BACKGROUND Pancreatic carcinoma possesses one of the highest lethality rates, highest drug-resistance, and highest incidence rates. The objective of this research was to enhance the efficacy and drug-resistance for pancreatic carcinoma by using inhibition of SIRT1 combined with gemcitabine therapy methods. METHODS Three pancreatic carcinoma cells (PANC-1 cells, BxPC-3 cells, and SW1990 cells)...

2014
Alexey Goltsov Yusuf Deeni Hilal S. Khalil Tero Soininen Stylianos Kyriakidis Huizhong Hu Simon P. Langdon David J. Harrison James Bown

The receptor tyrosine kinases (RTKs) are key drivers of cancer progression and targets for drug therapy. A major challenge in anti-RTK treatment is the dependence of drug effectiveness on co-expression of multiple RTKs which defines resistance to single drug therapy. Reprogramming of the RTK network leading to alteration in RTK co-expression in response to drug intervention is a dynamic mechani...

2016
Ian M. Hastings Eva Maria Hodel Katherine Kay

Most current antimalarial drugs are combinations of an artemisinin plus a 'partner' drug from another class, and are known as artemisinin-based combination therapies (ACTs). They are the frontline drugs in treating human malaria infections. They also have a public-health role as an essential component of recent, comprehensive scale-ups of malaria interventions and containment efforts conceived ...

2012
Aldric Hama Jacqueline Sagen

A number of mechanisms have been elucidated that maintain neuropathic pain due to spinal cord injury (SCI). While target-based therapeutics are being developed based on elucidation of these mechanisms, treatment for neuropathic SCI pain has not been entirely satisfactory due in part to the significant convergence of neurological and inflammatory processes that maintain the neuropathic pain stat...

Journal: :Journal of controlled release : official journal of the Controlled Release Society 2009
M Douglas Baumann Catherine E Kang Jason C Stanwick Yuanfei Wang Howard Kim Yakov Lapitsky Molly S Shoichet

We report the development of a series of physical hydrogel blends composed of hyaluronan (HA) and methyl cellulose (MC) designed for independent delivery of one or more drugs, from 1 to 28 days, for ultimate application in spinal cord injury repair strategies. To achieve a diversity of release profiles we exploit the combination of fast diffusion-controlled release of dissolved solutes from the...

Journal: :Neurology 2012
Nicholas P Poolos Lindsay N Warner Sophia Z Humphreys Stephen Williams

OBJECTIVE We retrospectively examined treatment records of developmentally disabled adults with highly refractory epilepsy to determine whether any combinations of 8 of the most commonly used antiepileptic drugs (AEDs) possessed superior efficacy. METHODS We obtained the treatment records from 148 developmentally disabled adults with refractory epilepsy cared for in 2 state-run institutions. ...

2008
Fabien Zoulim Claire Fournier

Despite the development of new nucleoside analogs, antiviral therapy of chronic hepatitis B remains a major clinical challenge. Indeed, because of both viral genome persistence and hepatitis B virus genome heterogeneity, these antivirals may select for drug-resistant mutants. The development of drug resistance is associated with liver disease progression. The progress made in virologic assays a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید